Abstract

New Mn(II), Fe(III), Co(II), and Ni(II) complexes with urate lowing drug febuxostat (FEB) and 2,2′-bipyridine (Bipy) were designed and depicted. Elemental analysis, molar conductance, magnetic measurements, FT-IR, UV–visible, 1H NMR, mass spectrometry (MS), X-ray diffraction (XRD) and thermal analyses (TG-DTG) studies were used to depict complexes. The FT-IR data revealed that the FEB and Bipy have two donating sites, the oxygen of the carboxylate group and the sulfur atom of the thiazole ring in FEB while, Bipy has two nitrogens of the pyridyl ring. Based on information from the magnetic and electronic spectra, an octahedral geometry was suggested for complexes. The nature of the water molecules and their thermal stability were investigated using TG-DTG analyses. By Coats-Redfern equations determined thermodynamic properties in addition to Horowitz-Metzger equations. The purpose XRD examination of compounds was used to determine the compounds (crystalline or amorphous), average crystallite size (Cs) and Crystallographic data. The bond angles, bond lengths, dipole moment, total energy and equilibrium geometry of metal complexes were investigated by DFT calculations. FEB exhibited an antioxidant action in addition to its metal complexes, with IC50 values of 0.124, 0.316, 0.635, 0.186 and 2.234 mg/mL for FEB, Mn(II), Fe(III), Co(II) and Ni(II) compounds, respectively. The molecular docking data demonstrated that the complexes have competent stabilizing scores of −6.66, −6.50, −7.18 and −7.59 kcal/mol, respectively. The data of Co(II) complex revealed the most promising potential xanthine oxidase inhibitory activity.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call